{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:16:23Z","timestamp":1793222183501,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,5,18]],"date-time":"2009-05-18T00:00:00Z","timestamp":1242604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1756-9966-28-65","type":"journal-article","created":{"date-parts":[[2009,5,19]],"date-time":"2009-05-19T07:26:00Z","timestamp":1242717960000},"source":"Crossref","is-referenced-by-count":50,"title":["Expression of phospho-ERK1\/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations"],"prefix":"10.1186","volume":"28","author":[{"given":"Qinglong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhulin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,18]]},"reference":[{"key":"152_CR1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0039-6109(16)45292-8","volume":"70","author":"RS Jones","year":"1990","unstructured":"Jones RS: Carcinoma of the gallbladder. The Surgical clinics of North America. 1990, 70: 1419-1428.","journal-title":"The Surgical clinics of North America"},{"key":"152_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2","volume":"75","author":"MT Carriaga","year":"1995","unstructured":"Carriaga MT, Henson DE: Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer. 1995, 75: 171-190. 10.1002\/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2.","journal-title":"Cancer"},{"key":"152_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/353670a0","volume":"353","author":"BJ Pulverer","year":"1991","unstructured":"Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR: Phosphorylation of c-jun mediated by MAP kinases. Nature. 1991, 353: 670-674. 10.1038\/353670a0.","journal-title":"Nature"},{"key":"152_CR4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0092-8674(91)90100-D","volume":"65","author":"Y Xiong","year":"1991","unstructured":"Xiong Y, Connolly T, Futcher B, Beach D: Human D-type cyclin. Cell. 1991, 65: 691-699. 10.1016\/0092-8674(91)90100-D.","journal-title":"Cell"},{"key":"152_CR5","doi-asserted-by":"publisher","first-page":"8773","DOI":"10.1073\/pnas.95.15.8773","volume":"95","author":"CP Webb","year":"1998","unstructured":"Webb CP, Van Aelst L, Wigler MH, Woude GF: Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proceedings of the National Academy of Sciences of the United States of America. 1998, 95: 8773-8778. 10.1073\/pnas.95.15.8773.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"152_CR6","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nrc1503","volume":"4","author":"JS Sebolt-Leopold","year":"2004","unstructured":"Sebolt-Leopold JS, Herrera R: Targeting the mitogen-activated protein kinase cascade to treat cancer. Nature Reviews. 2004, 4: 937-947. 10.1038\/nrc1503.","journal-title":"Nature Reviews"},{"key":"152_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00432-006-0129-1","volume":"132","author":"A Jinawath","year":"2006","unstructured":"Jinawath A, Akiyama Y, Yuasa Y, Pairojkul C: Expression of phosphorylated ERK1\/2 and homeodomain protein CDX2 in cholangiocarcinoma. Journal of cancer research and clinical oncology. 2006, 132: 805-810. 10.1007\/s00432-006-0129-1.","journal-title":"Journal of cancer research and clinical oncology"},{"key":"152_CR8","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.3748\/wjg.13.6470","volume":"13","author":"KJ Schmitz","year":"2007","unstructured":"Schmitz KJ, Lang H, Wohlschlaeger J, Sotiropoulos GC, Reis H, Schmid KW, Baba HA: AKT and ERK1\/2 signaling in intrahepatic cholangiocarcinoma. World J Gastroenterol. 2007, 13: 6470-6477. 10.3748\/wjg.13.6470.","journal-title":"World J Gastroenterol"},{"key":"152_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-230X-3-19","volume":"3","author":"H Huynh","year":"2003","unstructured":"Huynh H, Nguyen TT, Chow KH, Tan PH, Soo KC, Tran E: Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC gastroenterology. 2003, 3: 19-10.1186\/1471-230X-3-19.","journal-title":"BMC gastroenterology"},{"key":"152_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jhep.2007.08.018","volume":"48","author":"KJ Schmitz","year":"2008","unstructured":"Schmitz KJ, Wohlschlaeger J, Lang H, Sotiropoulos GC, Malago M, Steveling K, Reis H, Cicinnati VR, Schmid KW, Baba HA: Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. Journal of Hepatology. 2008, 48: 83-90. 10.1016\/j.jhep.2007.08.018.","journal-title":"Journal of Hepatology"},{"key":"152_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00535-007-2055-7","volume":"42","author":"H Hori","year":"2007","unstructured":"Hori H, Ajiki T, Mita Y, Horiuchi H, Hirata K, Matsumoto T, Morimoto H, Fujita T, Ku Y, Kuroda Y: Frequent activation of mitogen-activated protein kinase relative to Akt in extrahepatic biliary tract cancer. Journal of Gastroenterology. 2007, 42: 567-572. 10.1007\/s00535-007-2055-7.","journal-title":"Journal of Gastroenterology"},{"key":"152_CR12","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1158\/0008-5472.CAN-06-3214","volume":"67","author":"Q Wu","year":"2007","unstructured":"Wu Q, Kiguchi K, Kawamoto T, Ajiki T, Traag J, Thames H, Wistuba I, Thomas M, Vasquez KM, DiGiovanni J: Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model. Cancer Research. 2007, 67: 3794-800. 10.1158\/0008-5472.CAN-06-3214.","journal-title":"Cancer Research"},{"key":"152_CR13","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/j.1440-1746.2006.04373.x","volume":"21","author":"MM Javle","year":"2006","unstructured":"Javle MM, Yu J, Khoury T, Chadha KS, Iyer RV, Foster J, Kuvshinoff BW, Gibbs JF, Geradts J, Black JD, Brattain MG: Akt expression may predict favorable prognosis in cholangiocarcinoma. Journal of Gastroenterology and Hepatology. 2006, 21: 1744-1751. 10.1111\/j.1440-1746.2006.04373.x.","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"152_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc1609","volume":"5","author":"NE Hynes","year":"2005","unstructured":"Hynes NE, Lane HA: ERBB receptors and cancer: the complexity of targeted inhibitors. Nature Reviews. 2005, 5: 341-354. 10.1038\/nrc1609.","journal-title":"Nature Reviews"},{"key":"152_CR15","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1158\/1078-0432.CCR-05-1692","volume":"12","author":"F Leone","year":"2006","unstructured":"Leone F, Cavalloni G, Pignochino Y, Sarotto I, Ferraris R, Piacibello W, Venesio T, Capussotti L, Risio M, Aglietta M: Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma. Clin Cancer Res. 2006, 12: 1680-1685. 10.1158\/1078-0432.CCR-05-1692.","journal-title":"Clin Cancer Res"},{"key":"152_CR16","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0344-0338(11)80652-7","volume":"191","author":"CS Lee","year":"1995","unstructured":"Lee CS, Pirdas A: Epidermal growth factor receptor immunoreactivity in gallbladder and extrahepatic biliary tract tumours. Pathology, Research and Practice. 1995, 191: 1087-1091.","journal-title":"Pathology, Research and Practice"},{"issue":"3","key":"152_CR17","first-page":"262","volume":"22","author":"YM Zhou","year":"2003","unstructured":"Zhou YM, Li YM, Cao N, Feng Y, Zeng F: Significance of expression of epidermal growth factor (EGF) and its receptor (EGFR) in chronic cholecystitis and gallbladder carcinoma. Ai Zheng. 2003, 22 (3): 262-265.","journal-title":"Ai Zheng"},{"key":"152_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.7150\/ijms.5.285","volume":"5","author":"M Kaufman","year":"2008","unstructured":"Kaufman M, Mehrotra B, Limaye S, White S, Fuchs A, Lebowicz Y, Nissel-Horowitz S, Thomas A: EGFR expression in gallbladder carcinoma in North America. International Journal of Medical Sciences. 2008, 5: 285-291.","journal-title":"International Journal of Medical Sciences"},{"key":"152_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1078\/0344-0338-00016","volume":"197","author":"Y Ito","year":"2001","unstructured":"Ito Y, Takeda T, Sasaki Y, Sakon M, Yamada T, Ishiguro S, Imaoka S, Tsujimoto M, Higashiyama S, Monden M, Matsuura N: Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma. Pathology, Research and Practice. 2001, 197: 95-100. 10.1078\/0344-0338-00016.","journal-title":"Pathology, Research and Practice"},{"key":"152_CR20","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/gut.52.5.706","volume":"52","author":"A Weber","year":"2003","unstructured":"Weber A, Langhanki L, Sommerer F, Markwarth A, Wittekind C, Tannapfel A: Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut. 2003, 52: 706-712. 10.1136\/gut.52.5.706.","journal-title":"Gut"},{"key":"152_CR21","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/sj.bjc.6604047","volume":"97","author":"AW Hsing","year":"2007","unstructured":"Hsing AW, Gao YT, Tan TQ, Rashid A, Sakoda LC, Wang BS, Shen MC, Zhang BH, Niwa S, Chen J, Fraumeni JF: Gallstones and the risk of biliary tract cancer: a population-based study in China. British Journal of Cancer. 2007, 97: 1577-1582. 10.1038\/sj.bjc.6604047.","journal-title":"British Journal of Cancer"},{"key":"152_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrc1429","volume":"4","author":"II Wistuba","year":"2004","unstructured":"Wistuba II, Gazdar AF: Gallbladder Cancer: lessons from a rare tumour. Nature Reviews. 2004, 4: 695-706. 10.1038\/nrc1429.","journal-title":"Nature Reviews"},{"key":"152_CR23","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/hep.510300522","volume":"30","author":"J Park","year":"1999","unstructured":"Park J, Tadlock L, Gores GJ, Patel T: Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology. 1999, 30: 1128-1133. 10.1002\/hep.510300522.","journal-title":"Hepatology"},{"key":"152_CR24","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1053\/j.gastro.2005.03.010","volume":"128","author":"S Kobayashi","year":"2005","unstructured":"Kobayashi S, Werneburg NW, Bronk SF, Kaufmann SH, Gores GJ: Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells. Gastroenterology. 2005, 128: 2054-2065. 10.1053\/j.gastro.2005.03.010.","journal-title":"Gastroenterology"},{"key":"152_CR25","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/hep.20966","volume":"42","author":"H Isomoto","year":"2005","unstructured":"Isomoto H, Kobayashi S, Werneburg NW, Bronk SF, Guicciardi ME, Frank DA, Gores GJ: Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells. Hepatology. 2005, 42: 1329-1338. 10.1002\/hep.20966.","journal-title":"Hepatology"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-28-65.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-9966-28-65\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-28-65.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T08:02:14Z","timestamp":1548230534000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-28-65"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,18]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["152"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-28-65","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,18]]},"article-number":"65"}}